금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
TSMC profits surge amid relentless AI demand
World’s leading contract chipmaker beats estimates in third quarter...
British Pound holds gains as UK GDP and Industrial Production beat expectations
The British Pound (GBP) holds gains against the US Dollar (USD) on Wednesday’s early London session,...
UK economy "ekes out" 0.1% growth but outlook remains "challenging"
Monthly GDP unexpectedly grew by 0.1% in August 2026, following an unrevised growth of 0.4% in July ...
MasTec Trades at a Premium: Should Investors Buy the Stock or Fold?
MTZ's $21.4B backlog and AI infrastructure exposure support growth, but weak cash flow, Communications segment softness and premium valuation pose risks.
Zoetis (ZTS) Shares Drop After Earnings Revision
Impax Asset Management, based in London and specializing in sustainable investing, released its Q2 2026 investor letter for the “Impax US Sustainable Economy Fund”. The letter can be downloaded here. ...
Adobe (ADBE) Declines on Elevated Investor Hopes
Impax Asset Management, based in London and specializing in sustainable investing, released its Q2 2026 investor letter for the “Impax US Sustainable Economy Fund”. The letter can be downloaded here. ...
Capex Rebound Powers Applied Materials’ (AMAT) Performance
Impax Asset Management, based in London and specializing in sustainable investing, released its Q2 2026 investor letter for the “Impax US Sustainable Economy Fund”. The letter can be downloaded here. ...
Amgen drops on Novartis trial setback for heart therapy; BMO downgrades
One Stock Is Weighing Heavily on the Dow
The Dow lost 500 points early into Tuesday's trading session. Here's what's driving the loss. Most components in the blue chip index were in the red, but there was one name seeing the most dramatic do ...
Qualcomm, Amgen, Novartis, Corning, Boeing, and More Stocks That Explain Today’s Market
Amgen falls following Swiss drugmaker Novartis’ disappointing trial data. Novartis trades sharply lower.
Recession, rates, AI, oil: Stoltzfus isn’t hitting the brakes
Novartis’s failed trial for cholesterol drug leads to broad biopharma selloff
Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events.
Strategy expands STRC preferred stock buyback program; shares down
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday Amid Rising Oil Prices
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1% and the actively tr
Warren Buffett Says This Move Is the Key to Surviving a Stock Market Crash. Here's What History Says Comes Next
Financial history doesn't always repeat itself, but it tends to rhyme.